Rabia Gurses Ozden
Chief Development Officer, Akouos, Inc.
Companies
- Avalanche BiotechnologiesChief Medical Officer Jun 20, 2024 to now1
- OCULAR THERAPEUTIX, INCChief Medical Officer Jul 11, 2022 to Feb 6, 20242
- Avalanche BiotechnologiesBoard member Mar 18, 2022 to Jun 13, 20233
- Akouos, Inc.Chief Development Officer Jun 25, 2020 to Jun 25, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OCULAR THERAPEUTIX, INC OCUL153,054 shares5$957.4K at $6.25Feb 5, 2024
- Avalanche Biotechnologies ADVM0 shares6Dec 9, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 9, 2025U 85,000 shares of Avalanche Biotechnologies6
- Dec 9, 2025Granted 85,000 shares of Avalanche Biotechnologies6
- Dec 9, 2025U 8,125 shares of Avalanche Biotechnologies6
- Feb 25, 2025Granted 8,125 shares of Avalanche Biotechnologies7
- Feb 5, 2024Sold 6,346 shares at $4.86 of OCULAR THERAPEUTIX, INC5
- Feb 3, 2024Granted 66,633 shares of OCULAR THERAPEUTIX, INC5
- Jan 31, 2024Sold 7,764 shares at $4.95 of OCULAR THERAPEUTIX, INC8
- Jul 7, 2023Sold 832 shares at $4.93 of OCULAR THERAPEUTIX, INC9
- Feb 6, 2023Sold 6,416 shares at $4.24 of OCULAR THERAPEUTIX, INC10
- Jan 30, 2023Granted 55,556 shares of OCULAR THERAPEUTIX, INC11
- Jul 1, 2022Granted 6,667 shares of OCULAR THERAPEUTIX, INC12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Feb 27, 2025
- 8SEC EDGARForm 4 filed Feb 2, 2024
- 9SEC EDGARForm 4 filed Jul 11, 2023
- 10SEC EDGARForm 4 filed Feb 8, 2023
- 11SEC EDGARForm 4 filed Feb 1, 2023
- 12SEC EDGARForm 4 filed Jul 15, 2022